Genoss® DCB

DEVICE4 trials

Sponsors

Genoss Co., Ltd., Yonsei University, Seoul National University Hospital

Conditions

Coronary Artery DiseaseDe Novo StenosisIn-stent RestenosisPeripheral Artery Disease

Unknown Phase

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

CompletedNCT05096442

Genoss Co., Ltd.Coronary Artery Disease

Start: 2021-09-30End: 2023-11-21Updated: 2024-05-17

Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease

CompletedNCT05134545

Genoss Co., Ltd.De Novo Stenosis, Peripheral Artery Disease

Start: 2019-03-24End: 2023-06-30Updated: 2024-08-23

Safety and Efficacy of Paclitax Coated Balloon in Patients With Coronary In-stent Restenosis (ISR)

Active, not recruitingNCT05656118

Yonsei UniversityIn-stent Restenosis

Start: 2022-08-31End: 2028-12-31Target: 260Updated: 2025-07-08

Safety and Efficacy of Paclitaxel Coated PTCA Balloon Catheter With a Shellac Plus Vitamin E Excipient (GENOSS® DCB) in Patients With Coronary In-stent Restenosis (ISR): A Prospective, Multi-center, Observational Study

RecruitingNCT06104007

Seoul National University HospitalCoronary Artery Disease, In-stent Restenosis

Start: 2023-08-17End: 2028-12-31Target: 1000Updated: 2023-10-27

Related Papers

A Prospective Randomized Trial Comparing 2 Different Paclitaxel-Coated Balloons in De Novo Coronary Artery Disease.

2025-01-07